Skip to content
Home/Companies/Biotech/Ori Biotech
Ori Biotech

Ori Biotech

Biotech·UK·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Ori Biotech?

Ori Biotech is currently owned by Amadeus Capital Partners through Amadeus IV Digital Prosperity Fund (2013 vintage), since 2020.

Hand-verified · updated 2026-07-28

Amadeus Capital Partners
Investor
Amadeus Capital Partners
Amadeus IV Digital Prosperity Fund · 2013 · Growth

Key facts

HQUK
SectorBiotech
StatusActive
Websiteoribiotech.com

More from Amadeus IV Digital Prosperity Fund

Other portfolio companies in the same fund.

Healx
Healx
Active
BiotechUK
Altana AI
Altana AI
Active
AI/MLUS· 2020
Creditas
Creditas
Active
FintechBrazil· 2018
Paragraf
Paragraf
Active
Deep TechUK· 2018
ContactEngine
Exited 2021
AI/MLUK· 2016
to
Doctify
Active
HealthTechUK· 2016

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Inits Group
Inits Group
Active
Sofilaro GestionFrance
Track Ori Biotech

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Ori Biotech.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue